Brought to you by 
Inverness buys 76% of Standard Diagnostics for KRW242bn
09 Feb 2010
Executive Summary
Inverness Medical Innovations has agreed to acquire 75.79% of public South Korean firm Standard Diagnostics for approximately KRW242bn ($215.6mm) in cash, or KRW40k per share.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Chemistry, Immunoassay
- Glucose Testing
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness buys 76% of Standard Diagnostics for KRW242bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice